Exploring histological predictive biomarkers for immune checkpoint inhibitor therapy response in non-small cell lung cancer
Treatment challenges persist in advanced lung cancer despite the development of therapies beyond the traditional platinum-based chemotherapy. The early 2000s marked a shift to tyrosine kinase inhibitors targeting epidermal growth factor receptor, ushering in personalized genetic-based treatment. A f...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology,
2024-03-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|